Get started
Author

Kannan Subramaniam

Observed names: K Subramaniam, K. Subramaniam, Subramaniam Kannan
Institution: Viatris
ORCID: 0000-0001-5551-4103
Observed ORCID: 0000-0001-5551-4103
OpenAlex ID: A5056286823
A Narrative Review of the Patient Journey Through the Lens of Non-communicable Diseases in Low- and Middle-Income Countries
2020 · Ratna Devi, Komal Kanitkar, et al. · Advances in Therapy · 102
PDF
Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India
2016 · Anandhasayanam Aravamuthan, Mohanavalli Arputhavanan, et al. · Journal of Pharmaceutical Policy and Practice · 85
PDF
Nonadherence to statins: individualized intervention strategies outside the pill box
2018 · Peter Lansberg, Andre Lee, et al. · Vascular Health and Risk Management · 83
PDF
Understanding short-term blood-pressure-variability phenotypes: from concept to clinical practice
2018 · Veerendra Melagireppa Chadachan, Min Tun Ye, et al. · International Journal of General Medicine · 75
Massive open online courses (MOOCs) for continuing medical education – why and how?
2019 · Sajita Setia, Jam Chin Tay, et al. · Advances in Medical Education and Practice · 65
PDF
Systemic Solutions for Addressing Non-Communicable Diseases in Low- and Middle-Income Countries
2020 · Aakash Ganju, Alessandra C Goulart, et al. · Journal of Multidisciplinary Healthcare · 61
PDF
Bridging the “Know-Do” Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science
2023 · James F Donohue, J Stuart Elborn, et al. · Journal of Healthcare Leadership · 58
A Methodology for Mapping the Patient Journey for Noncommunicable Diseases in Low- and Middle-Income Countries
2021 · Tanaya Bharatan, Ratna Devi, et al. · Journal of Healthcare Leadership · 56
PDF
The Impact of COVID-19 on the Care of Patients With Noncommunicable Diseases in Low- and Middle-Income Countries: An Online Survey of Patient Perspectives
2021 · Ratna Devi, Felicity Goodyear-Smith, et al. · Journal of Patient Experience · 29
Evolving role of pharmaceutical physicians in medical evidence and education
2018 · Sajita Setia, Nicola Ryan, et al. · Advances in Medical Education and Practice · 29
PDF
The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries
2021 · Chris Bullen, Jessica McCormack, et al. · Primary Health Care Research & Development · 28
PDF
Ambulatory and home blood pressure monitoring: gaps between clinical guidelines and clinical practice in Singapore
2017 · Sajita Setia, Kannan Subramaniam, et al. · International Journal of General Medicine · 28
PDF
Hypertension and blood pressure variability management practices among physicians in Singapore
2017 · Sajita Setia, Kannan Subramaniam, et al. · Vascular Health and Risk Management · 20
PDF
Inculcating Dispositional Optimism for Prevention of Mental and Substance Use Disorders Throughout and After the Coronavirus Disease-19 Pandemic
2021 · Sajita Setia, Chris Krägeloh, et al. · Alternative and Complementary Therapies · 11
Antimicrobials Prescribing Patterns in Urban and Rural Hospitals-Determinants and Proposed Interventions
2013 · Apollo James, Arul Prakasam, et al. · 2
A Review of the Impact of Platform Therapies (DMTs) on Associated Clinical Symptoms of Multiple Sclerosis
2025 · Santosh Shirol, Kannan Subramaniam, et al. · Journal of Multidisciplinary Healthcare · 1
PDF
Public Private Partnerships Delivering Smart Health to Combat the Tsunami of Noncommunicable Diseases
2020 · Subramaniam Kannan · Studies in health technology and informatics · 1
To Assess the Change in Quality of Care Leading to Change in Outcome When a Pharmacist Joins the Conventional Alcohol De-Addiction Treatment Team in a Residential De-addiction Centre at Chennai, Tamilnadu, India
2013 · А. Ф. Ан, hasayanam, et al. · Research and reviews : journal of pharmacy and pharmaceutical sciences · 1
Changes in Anxiety Severity and Acceptability of Venlafaxine in Generalized Anxiety Disorder in the United States: Results From a Real-World Study
2026 · Christoph U Correll, Kannan Subramaniam, et al. · Neuropsychiatric Disease and Treatment
PDF
Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice
2026 · Christoph Correll, Pradeep Purushottamahanti, et al. · Neuropsychiatric Disease and Treatment
Review of the impact of short-term use of alprazolam on cognitive, psychomotor, and quality-of-life impairments associated with anxiety disorders
2026 · Humberto Nicolini, Santosh Basavraj Shirol, et al. · CNS Spectrums
PDF
366. Leveraging Digital Enablers to Amplify the Evidence for Clinical Practice in Treatment-resistant Schizophrenia
2025 · K Subramaniam, S Shirol · The International Journal of Neuropsychopharmacology
PDF
496. the Benefits of Clozapine Beyond Its Antipsychotic Properties in Treatment-resistant Schizophrenia
2025 · K Subramaniam, S Shirol · The International Journal of Neuropsychopharmacology
PDF
A Prospective Pharmacovigilance Study in the Respiratory Tract Infections in Pulmonary Medicine Department of a Tertiary Care Hospital
2025 · Subramaniam Kannan, SyedIbrahim. S SyedIbrahim. S, et al. · International Journal of Pharmaceutical Research and Applications
PDF
62 Creating and sustaining an expert forum on noncommunicable diseases in low- and middle-income countries
2020 · Kannan Subramaniam, Barrett Jeffers, et al. · BMJ Leader
PDF
Works count: 28
Citation count: 735
H-index: 13
I10-index: 14
Year
Topic
Type